GlaxoSmithKline Gets Momelotinib with US$1.9 B Sierra Oncology Buyout

By Sasha Yachu

Pharma Deals Review: Vol 2022 Issue 4 (Table of Contents)

Published: 21 Apr-2022

DOI: 10.3833/pdr.v2022.i4.2685     ISSN: 1756-7874

Section: Mergers & Acquisitions



GlaxoSmithKline (GSK) has agreed to acquire Sierra Pharma for US$55 per share, representing a total transaction value of US$1...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details